BridgeBio Pharma, Inc. (BBIO) Total assets 2019–2025
BridgeBio Pharma, Inc. (BBIO) total assets at each fiscal year-end, per SEC filings.
$936.0MFY2025 · since FY2019: $631.7M → $936.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $936.0M | +1.8% |
| FY2024 | $919.3M | +68.3% |
| FY2023 | $546.4M | -12.3% |
| FY2022 | $623.0M | -38.5% |
| FY2021 | $1.0B | +43.9% |
| FY2020 | $703.6M | +11.4% |
| FY2019 | $631.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice